$2.40
-0.16[-6.25%]
At close: Apr 24
$2.40
0[0.00%]
After Hours: 6:49PM EDT
Standard BioTools
(NASDAQ:LAB)Latest News for Standard BioTools Stock (NASDAQ:LAB)
Standard BioTools Stock (NASDAQ: LAB)
Categories: All
Tuesday, April 16, 2024
Thursday, April 04, 2024
- Standard BioTools shares are trading higher after Jefferies initiated coverage on the stock with a Buy rating and a price target of $3.25.Benzinga Newsdesk - Apr 4, 2024, 7:49AM
- Jefferies Initiates Coverage On Standard BioTools with Buy Rating, Announces Price Target of $3.25Benzinga Newsdesk - Apr 4, 2024, 7:21AM
Wednesday, April 03, 2024
Thursday, March 07, 2024
Friday, March 01, 2024
Wednesday, February 28, 2024
- Standard BioTools Expects Combined Company Revenue Of $200M-$205M, Est $120.2MBenzinga Newsdesk - Feb 28, 2024, 4:40PM
- Standard BioTools Q4 2023 GAAP EPS $(0.25) Misses $(0.24) Estimate, Sales $28.19M Beat $24.90M EstimateBenzinga Newsdesk - Feb 28, 2024, 4:05PM
- Earnings Scheduled For February 28, 2024Benzinga Insights - Feb 28, 2024, 6:24AM
Monday, February 26, 2024
Wednesday, February 07, 2024
Monday, January 08, 2024
Friday, January 05, 2024
Thursday, December 28, 2023
Tuesday, December 26, 2023
Thursday, December 21, 2023
Wednesday, December 20, 2023
- Skye Fund III Issues Letter Regarding Opposition To SomaLogic's Proposed Merger With Standard BioTools; Believes That The Proposed Merger Grossly Undervalues SomaLogicBenzinga Newsdesk - Dec 20, 2023, 9:11AM
- Skye Fund III Issued An Open Letter To SomaLogic's Shareholders Regarding Its Opposition To The Company's Proposed Merger With Standard BioTools And Its Intention To Vote Against The Proposed MergerBenzinga Newsdesk - Dec 20, 2023, 9:05AM
Monday, December 04, 2023
Tuesday, November 07, 2023
- Standard BioTools Sees Total Revenue Of $100M-$105M For FY23; Expects Non-GAAP Gross Margin Of ~60%Benzinga Newsdesk - Nov 7, 2023, 7:29PM
- Standard BioTools Q3 2023 EPS $(0.27) Down From $(0.26) YoY, Sales $25.37M Down From $25.65M YoYBenzinga Newsdesk - Nov 7, 2023, 4:12PM
- Earnings Scheduled For November 7, 2023Benzinga Insights - Nov 7, 2023, 6:34AM
Wednesday, October 04, 2023
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Oct 4, 2023, 1:31PM
- Standard BioTools shares are trading lower after the company announced it will combine with SomaLogic in an all-stock merger.Benzinga Newsdesk - Oct 4, 2023, 12:08PM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Oct 4, 2023, 9:06AM
- Standard BioTools Raises FY23 Revenue Outlook From $80M-$84M To $100M-$105MBenzinga Newsdesk - Oct 4, 2023, 8:15AM
- Standard BioTools And SomaLogic To Combine In All-Stock Merger Creating A Diversified Leader In Life Sciences Tools; Standard BioTools Shareholders Will Own ~43% Of The Combined Co, And SomaLogic Shareholders Will Own ~57% Of The Combined CoBenzinga Newsdesk - Oct 4, 2023, 8:14AM
- Bloomberg Reported Earlier, Standard BioTools And SomaLogic Are Said To Near Merger DealCharles Gross - Oct 4, 2023, 7:38AM
Tuesday, August 08, 2023
Wednesday, July 12, 2023
- Standard BioTools Get a Buy Rating, Analyst Cites Unique Technology, Management and BoardVandana Singh - Jul 12, 2023, 1:58PM
- Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2023Benzinga Insights - Jul 12, 2023, 11:02AM
- Keybanc Initiates Coverage On Standard BioTools with Overweight Rating, Announces Price Target of $4Benzinga Newsdesk - Jul 12, 2023, 4:29AM